UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: AtomoxetinActavis-18mg-Capsule-SE-AJ-MPD-BBDL

Atomoxetin Actavis 18 mg Kapsel, hård

MPID: SE-100000064-00052683
EURDID: 262

Full name: Atomoxetin Actavis 18 mg Kapsel, hård

- Scientific Name Part: Atomoxetin Actavis

- Strength part: 18 mg

- Pharmaceutical dose form part: Kapsel, hård

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Capsule, hard

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000097726 atomoxetine

Marketing Authorisation 1 of 1

Authorisation number: 52683

Region: Kingdom of Sweden

Marketing authorisation holder: Actavis Group PTC ehf.

Identifier:

  • LOC-100001873

Status: Valid (2016-05-12)

Package 1 of 1

PCID:

Description:
Blister, 28 kapslar

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 28 Capsule

Package: 1 Box (Cardboard)

Containing:

Package: 2 Blister (PolyVinyl Chloride) (Aluminium) (PolyVinylidene Chloride)

Containing: 14 Capsule

Manufactured Item

Dose form: Capsule, hard

Unit of presentation: Capsule

Ingredient

Role: Active

Substance: Atomoxetine hydrochloride

Presentation strength: 20.57 milligram(s) / 1 Capsule

Reference strength:
Atomoxetine 18 milligram(s) / 1 Capsule